Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 1/2 1

Status

Completed 4Withdrawn 2Recruiting 2Terminated 1

Sponsor Class

OTHER 2NIH 2

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Gynecologic 9Gastrointestinal 5Thoracic 4Breast 4Genitourinary 3Dermatologic 3Head & Neck 2CNS 2Tumor-Agnostic 1Sarcoma 1Plasma cell 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Breast Neoplasms 4Prostatic Neoplasms 1Neoplasms 1Lymphadenopathy 1Lung Neoplasms 1Colonic Neoplasms 1Breast Neoplasms, Male 1Adenoviridae Infections 1Adenocarcinoma 1

Interventions

Trastuzumab 379Paclitaxel 369Cyclophosphamide 338Docetaxel 314Capecitabine 198Doxorubicin 196Letrozole 184Tamoxifen 154Carboplatin 153Fulvestrant 136Bevacizumab 129Anastrozole 120exemestane 119Lapatinib 117Epirubicin 116Gemcitabine 112Radiotherapy 107palbociclib 94Exercise 87Fluorouracil 83Vinorelbine 82Surveys and Questionnaires 81pertuzumab 77Albumin-Bound Paclitaxel 76Filgrastim 71130-nm albumin-bound paclitaxel 64pembrolizumab 63Everolimus 59Cisplatin 59eribulin 58

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Vaccines × Breast × Clear all
NCT06429020 2024-05-24

Sonography for COVID-19 Vaccines Related Reactive Lymphadenopathy

Chimei Medical Center

Completed
1,089 enrolled
Breast

Lymphadenopathy, Breast Neoplasms

NCT01730118 2022-09-10

Ad/HER2/Neu Dendritic Cell Cancer Vaccine Testing

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
33 enrolled 18 charts
Breast

Adenocarcinoma, Breast Neoplasms

NCT03384316 2020-09-09

Multi-Targeted Recombinant Ad5 (CEA/MUC1/Brachyury) Based Immunotherapy Vaccine Regimen in People With Advanced Cancer

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
11 enrolled 18 charts
BreastGastrointestinalGenitourinaryThoracic

Adenoviridae Infections, Breast Neoplasms, Colonic Neoplasms, Lung Neoplasms, Neoplasms, Prostatic Neoplasms

NCT01042535 2018-04-11

Vaccine Therapy and 1-MT in Treating Patients With Metastatic Breast Cancer

H. Lee Moffitt Cancer Center and Research Institute

Phase 1/2 Completed
44 enrolled 10 charts
Breast

Breast Neoplasms, Breast Neoplasms, Male

Data powered by HemOnc (CC BY 4.0) Colophon âš¡